Final Report of the 2011-2012 Bylaws and Policy Development Committee

doi:10.5688/ajpe769S19

A. MEMBERSHIP RESOLUTIONS

Resolution #1-5: Adopted by the AACP House of Delegates

Resolutions #1-5 are approved by the House of Delegates, accepting into institutional membership Cedarville University School of Pharmacy, Fairleigh Dickinson University Medco School of Pharmacy, Manchester University College of Pharmacy, Marshall University School of Pharmacy, and South College School of Pharmacy.

B. POLICY RESOLUTION

Policy Resolution #1 (Source: AACP Individual Members)

AACP recommends that each school or college of pharmacy:

1. Publish annually, amend publicly, and adhere to its application, acceptance and admission procedures.
2. Require a deposit no earlier than April 1^st to hold seat in the matriculating PharmD class.
3. Offer applicants the option of voluntarily paying deposits prior to April 1. In addition, after the April 1^st deposit date, offers made on or after this date can require the deposit within two weeks of the offer date or request for deposit date (whichever is later). No other enticements may be offered to applicants to deposit prior to April 1^st (ex: reduced deposit, tuition discounts, scholarships, etc.).
4. Set the policy and practice of refunding deposits after April 1st at their own discretion.

The Bylaws and Policy Development Committee has referred this resolution back to the originators for refinement and clarification because, in its current form, it is determined to be inconsistent with current AACP Bylaws.

C. POLICY STATEMENTS

Policy Statement #1 (Source: 2011-12 Standing Committee on Academic Affairs)

All pharmacy faculty members have the responsibility to practice as scholarly teachers. Scholarly teaching is achieved when faculty use an evidence-based approach to deliver their discipline-specific content knowledge as well as their pedagogical knowledge of teaching and motivation.

The Bylaws and Policy Development Committee recommends adoption of this statement as amended.

Policy Statement #2 (Source: 2011-12 Standing Committee on Professional Affairs)

AACP affirms that preceptor development is essential to enhance the quality of experiential education and believes that preceptors should possess competencies that include, but are not limited to, leadership/management skills, embodiment of the development of a practice philosophy focused on improving patient outcomes, role modeling as a practitioner, commitment to excellence in scholarly teaching, effective communication skills, and encouragement of self-directed learning.

The Bylaws and Policy Development Committee recommends adoption of this statement as amended.

Policy Statement #3 (Source: 2011-12 Standing Committee on Professional Affairs)

AACP encourages schools and colleges of pharmacy to develop and maintain mechanisms for preceptor recognition.

The Bylaws and Policy Development Committee has referred this statement to the originator because it is a suggestion and not a statement of educational policy.

Policy Statement #4 (Source: 2011-12 Standing Committee on Advocacy)

AACP endorses the scholarship of evidence-based education that includes, but is not limited to, assessment of teaching and student learning and the integration and application of patient and professional advocacy.

The Bylaws and Policy Development Committee has referred this statement to its originator for clarification.

Policy Statement #5 (Source: 2011-12 Standing Committee on Advocacy)

AACP endorses evidence-based education, continuous quality improvement, rigorous accreditation standards and assessment.

The Bylaws and Policy Development Committee recommends adoption of this statement.

Policy Statement #6 (Source: 2011-12 Standing Committee on Advocacy)

AACP supports efforts to develop and maintain strong, mutually beneficial community-campus partnerships that demonstrate and recognize the value of education and science scholarship and innovative practice models that improve the quality of individual and community health outcomes.

The Bylaws and Policy Development Committee recommends adoption of this statement as amended.

Policy Statement #7 (Source: 2011-12 Council of Deans)

AACP supports the development of accreditation criteria that are based upon the school of pharmacy’s ability to develop measurable behavioral competencies in student pharmacists that incorporate knowledge and skills, as well as professional attitudes and values.

The Bylaws and Policy Development Committee recommends adoption of this statement.

Policy Statement #8 (Source: 2011-12 Council of Deans)

AACP shall pursue the development of resource kits (including OSCEs) and educational programming to assist colleges and schools of pharmacy in developing curricula, teaching methodologies, and assessment techniques that promote competency-based pharmacy education.

The Bylaws and Policy Development Committee has referred this statement to the Board of Directors’ Strategic Planning Committee.

D. BYLAWS AMENDMENTS

Bylaws Amendment #1 (Source: 2011-12 Bylaws and Policy Development Committee)

Article IX. Officers: The officers of this Association shall be a President, an Immediate Past President, a President-elect, a Treasurer, a Speaker of the House of Delegates and an Executive Vice President/Secretary (Executive Vice President and CEO). The Association Officers will serve as the Executive Committee of the Board and may act on business on behalf of the Board of Directors between meetings of the full Board, with such actions to be reported to the full Board as soon as possible.

The Bylaws and Policy Development Committee recommends adoption of this amendment.

Bylaws Amendment #2 (Source: 2011-12 Bylaws and Policy Development Committee)

Article V, Section 6. Organizing and Financing of Sections: The establishment of Sections is approved by the Board of Directors based on the needs of faculty, administrators, and professional staff members that support the mission of academic pharmacy. The Board of Directors will develop criteria for forming sections. Each Section shall be composed of individual active, affiliate, student, and emeritus members. The individual Sections will focus their programs and activities on academic and administrative matters.

The Bylaws and Policy Development Committee recommends adoption of this amendment.

Respectfully submitted,

Committee Members:

Susan M. Meyer, PhD, Chair (University of Pittsburgh)

Patricia A. Marken, PharmD (University of Missouri-Kansas City)

Alok Bhushan, PhD (Idaho State University)

Brandon T. Jennings, PharmD (The University of Utah)

Evan T. Robinson, PhD (Western New England University)

John A. Pieper, PharmD (St Louis College of Pharmacy)

Cynthia J. Boyle, PharmD, Speaker ex-officio, (University of Maryland Eastern Shore)

Lucinda L. Maine, PhD, Staff Liaison